HY-103346-1mg
|
MedChemexpress LLC
|
MMPSI [CAS 220509-74-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-103346-10mg
|
MedChemexpress LLC
|
MMPSI [CAS 220509-74-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-103346-100mg
|
MedChemexpress LLC
|
MMPSI [CAS 220509-74-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-103346-25mg
|
MedChemexpress LLC
|
MMPSI [CAS 220509-74-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-103346-5mg
|
MedChemexpress LLC
|
MMPSI [CAS 220509-74-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-103346-50mg
|
MedChemexpress LLC
|
MMPSI [CAS 220509-74-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99022-1mg
|
MedChemexpress LLC
|
Gantenerumab [CAS 1043556-46-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99022-10mg
|
MedChemexpress LLC
|
Gantenerumab [CAS 1043556-46-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99022-5mg
|
MedChemexpress LLC
|
Gantenerumab [CAS 1043556-46-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99185-1mg
|
MedChemexpress LLC
|
Bapineuzumab [CAS 648895-38-9]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99185-10mg
|
MedChemexpress LLC
|
Bapineuzumab [CAS 648895-38-9]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99185-5mg
|
MedChemexpress LLC
|
Bapineuzumab [CAS 648895-38-9]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99216-1mg
|
MedChemexpress LLC
|
Ponezumab [CAS 1178862-65-1]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99216-5mg
|
MedChemexpress LLC
|
Ponezumab [CAS 1178862-65-1]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99317-1mg
|
MedChemexpress LLC
|
Solanezumab [CAS 955085-14-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99317-10mg
|
MedChemexpress LLC
|
Solanezumab [CAS 955085-14-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99317-5mg
|
MedChemexpress LLC
|
Solanezumab [CAS 955085-14-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99356-1mg
|
MedChemexpress LLC
|
Cinpanemab [CAS 2094516-02-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99356-10mg
|
MedChemexpress LLC
|
Cinpanemab [CAS 2094516-02-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99356-5mg
|
MedChemexpress LLC
|
Cinpanemab [CAS 2094516-02-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99399-1mg
|
MedChemexpress LLC
|
Semorinemab [CAS 2159141-27-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99399-10mg
|
MedChemexpress LLC
|
Semorinemab [CAS 2159141-27-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99399-5mg
|
MedChemexpress LLC
|
Semorinemab [CAS 2159141-27-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99648-1mg
|
MedChemexpress LLC
|
Gosuranemab [CAS 1788032-39-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99648-10mg
|
MedChemexpress LLC
|
Gosuranemab [CAS 1788032-39-2]
|
|
Neuroscience-Neurodegeneration
|
|